Platelet-to-high-density lipoprotein cholesterol ratio and risk of major adverse cardiovascular events in patients with type 2 diabetes: A real-world retrospective cohort study.
BACKGROUND Despite advances in evidence-based treatment, patients with type 2 diabetes mellitus (T2DM) remain at substantial cardiovascular risk. The platelet-to-high-density lipoprotein cholesterol ratio (PHR) integrates platelet-related thrombotic activity and HDL-related vascular protection, but its association with...